Board approves Bimapay stake purchase and preferential capital raising

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

MUFIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹122.00

prior close

₹123.64

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-1.2% vs market

Non Banking Financial Company (NBFC) peers, median of 205sector+0.3%-1.1% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.1 pts less than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-3.4

15m

-2.5

30m

-2.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+0.4-1.2+0.3-1.1

Next day

-6.9+0.0-6.9+0.1-7.0

-9.7-0.2-9.5-0.2-9.5

-8.5+0.7-9.2-0.0-8.5

-7.4+0.6-8.0+0.3-7.7

-10.2+0.5-10.8+0.2-10.4

-5.4+0.3-5.7-0.9-4.5

15d

-9.0-1.5-7.5-1.8-7.1

-11.7-6.6-5.2-4.4-7.3

+0.0-3.2+3.2-3.7+3.7

-5.4-5.2-0.2-10.0+4.7

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 205Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved agreements to acquire 19.16% of Bimapay Finsure, an IT services firm, for about Rs 41.33 crore through a share swap. It also approved up to 3.91 crore equity shares at Rs 98 each, including 42.30 lakh swap shares, plus 76.53 lakh promoter warrants at Rs 98. The company also approved up to Rs 90 crore in listed, secured, non-convertible debentures and plans to enter the money-changing business. Approvals are pending.

Likely market impact

Could support growth, but substantial equity dilution and added debt may weigh on the stock; approvals are pending.